Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ Remdesivir solidarity trials WHO ]

Results 1 to 11 of 11
Reuters
November 20, 2020
The advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise


BusinessToday.In
October 17, 2020
India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients


Reuters
October 16, 2020
The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


BusinessToday.In
New Delhi, June 18, 2020
Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government


E Kumar Sharma
June 17, 2020
WHO Chief Scientist Dr Soumya Swaminathan points out that taking Dexamethasone, which is a corticosteroid, inappropriately could worsen the situation in an COVID-19 infection


PTI
June 2, 2020
The drug has been allowed for restricted emergency use for treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children hospitalised with severe symptoms, subject to several safeguards, the source said


PTI
May 30, 2020
Gilead Sciences Inc have entered into non-exclusive licensing agreements with pharma firms including three domestic majors Cipla, Jubilant Life Sciences and Hetero for manufacture and distribution of remdesivir


E Kumar Sharma
New Delhi, May 27, 2020
Coronavirus crisis: WHO is currently assessing the use of hydroxychloroquine on COVID-19 patients within the Solidarity Trial. The hydroxychloroquine arm of the trial has been paused as a precaution while the safety data is being reviewed.


PB Jayakumar
April 23, 2020
European Medicines Agency said recent studies have reported serious, in some cases fatal, heart rhythm problems with chloroquine or hydroxychloroquine, particularly when taken in high doses or in combination with the antibiotic azithromycin


E Kumar Sharma
March 22, 2020
At one end, there is work on repurposed anti-HIV medicines and at the other, repurposed antimalarial drugs like choroquine (hydroxychloroquine) along with some antibiotics like Azithromycin are being advocated


PAGES 1 OF 1